An Observational Study of RoActemra/Actemra (Tocilizumab) in Rheumatoid Arthritis Patients

Update Il y a 4 ans
Reference: NCT01615419

Woman and Man

  • | Country :
  • Greece
  • | organs :
  • -
  • | Specialty :
  • -

Extract

This multi-center, observational study will evaluate the use in clinical practice and efficacy of RoActemra/Actemra (tocilizumab) in patients with rheumatoid arthritis. Eligible patients initiated on RoActemra/Actemra treatment according to the approved label will be followed for 6 months.


Inclusion criteria

  • Rheumatoid Arthritis

Links